Progressive multifocal leukoencephalopathy in the United States, 1979-1994: increased mortality associated with HIV infection
- PMID: 9778596
- DOI: 10.1159/000026184
Progressive multifocal leukoencephalopathy in the United States, 1979-1994: increased mortality associated with HIV infection
Abstract
To examine trends in progressive multifocal leukoencephalopathy (PML) mortality in the United States, we analyzed PML death rates and deaths for 1979 through 1994, using US multiple cause-of-death data. During the 16-year study period 3,894 PML deaths were reported. The age-adjusted death rate increased more than 20-fold, from less than 0.2 per million persons before 1984 to 3.3 per million persons in 1994. The increase was attributable to infection with human immunodeficiency virus (HIV) which was recorded on 2,267 (89.0%) of 2.546 death records from 1991 through 1994. PML age-adjusted death rates increased abruptly for all males beginning in 1984 and for black females in 1990. Only a small increase was observed for white females. In 1994, PML was reported in 2.1% of white males who died with HIV-associated disease compared with 1.2% of white females and 1.0% of black males and females who died of similar causes. The epidemic of PML deaths is increasing in parallel with the AIDS epidemic. The increase in HIV-associated PML deaths, first noted among males, has also become apparent among females and probably reflects the increasing importance of drug use and heterosexual transmission of HIV. The reason for the higher prevalence of PML among white males with HIV infection is unknown.
Similar articles
-
Epidemiology of progressive multifocal leukoencephalopathy in the United States: analysis of national mortality and AIDS surveillance data.Neurology. 1991 Nov;41(11):1733-6. doi: 10.1212/wnl.41.11.1733. Neurology. 1991. PMID: 1944901
-
Progressive multifocal leukoencephalopathy deaths in the USA, 1979-2005.Neuroepidemiology. 2010;35(3):178-84. doi: 10.1159/000311014. Epub 2010 Jul 24. Neuroepidemiology. 2010. PMID: 20664291
-
Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study.Clin Infect Dis. 2009 May 15;48(10):1459-66. doi: 10.1086/598335. Clin Infect Dis. 2009. PMID: 19348592
-
[Progressive multifocal leukoencephalopathy in AIDS].Ned Tijdschr Geneeskd. 1992 Mar 14;136(11):521-6. Ned Tijdschr Geneeskd. 1992. PMID: 1552955 Review. Dutch.
-
[Review of progressive multifocal leukoencephalopathy].Nihon Rinsho. 2007 Aug;65(8):1487-94. Nihon Rinsho. 2007. PMID: 17695289 Review. Japanese.
Cited by
-
Induction of Brain Tumors by the Archetype Strain of Human Neurotropic JCPyV in a Transgenic Mouse Model.Viruses. 2021 Jan 22;13(2):162. doi: 10.3390/v13020162. Viruses. 2021. PMID: 33499370 Free PMC article.
-
Microarray analysis of glial cells resistant to JCV infection suggests a correlation between viral infection and inflammatory cytokine gene expression.Virology. 2007 Sep 30;366(2):394-404. doi: 10.1016/j.virol.2007.05.016. Epub 2007 Jun 6. Virology. 2007. PMID: 17555786 Free PMC article.
-
Brincidofovir inhibits polyomavirus infection in vivo.mBio. 2024 Aug 14;15(8):e0104924. doi: 10.1128/mbio.01049-24. Epub 2024 Jul 2. mBio. 2024. PMID: 38953354 Free PMC article.
-
Diffusion-weighted imaging in patients with progressive multifocal leukoencephalopathy.Eur Radiol. 2008 May;18(5):1024-30. doi: 10.1007/s00330-007-0845-1. Epub 2008 Mar 7. Eur Radiol. 2008. PMID: 18324406
-
Interferon beta1-a and selective anti-5HT(2a) receptor antagonists inhibit infection of human glial cells by JC virus.Virus Res. 2008 Mar;132(1-2):97-103. doi: 10.1016/j.virusres.2007.11.002. Virus Res. 2008. PMID: 18093678 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical